P.006 Cost-effectiveness of Lecanemab for the treatment of early Alzheimer's Disease: a Canadian societal perspective.Published in:2025By:Burn, O;Trueman, D;Molloy, K;Haynes, AE;Castellano, K;Pastor, L;Wong, E;Rothwell, S;Jang, S;Bodnar, CPublication type:Abstract
